# Sutro Biopharma, Inc.: Form 8-K, filed Jun 26, 2023

- Company: [Sutro Biopharma, Inc.](/companies/stro.md) (CIK 1382101)
- Form: 8-K
- Filed: 2023-06-26
- Accepted by EDGAR: Jun 26, 2023, 08:01 ET
- Period: 2023-06-21
- Accession: 0000950170-23-029731
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1382101/000095017023029731/stro-20230621.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1382101/000095017023029731/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1382101/000095017023029731/stro-20230621.htm

Filed Jun 26, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-029731. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.